myelodysplastic syndromes
Showing NaN - NaN of 103
MDS Trial in Houston (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2023
Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)
Not yet recruiting
- Leukemia
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 28, 2023
Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Rochester, Minnesota
- +1 more
Feb 15, 2023
Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +12 more
Jan 23, 2023
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
MDS Trial in Worldwide (Talacotuzumab, Daratumumab)
Completed
- Myelodysplastic Syndromes
-
Saint Louis, Missouri
- +20 more
Dec 28, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Fountain Valley, California
- +28 more
Nov 18, 2022
MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Azacitidine
- +2 more
-
Hackensack, New Jersey
- +6 more
Nov 18, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- DSP107
- +2 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022
MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)
Recruiting
- Myelodysplastic Syndromes
- Myeloproliferative Chronic Myelomonocytic Leukemia
- Cladribine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia (AML)
- +3 more
-
Birmingham, Alabama
- +26 more
Sep 12, 2022
MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)
Active, not recruiting
- Myelodysplastic Syndromes
- Oral Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +65 more
Aug 19, 2022
MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)
Terminated
- MDS
- Myelodysplastic Syndromes
- APR-548 + Azacitidine
-
Tampa, Florida
- +3 more
Jul 20, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- CFI-400945
- +2 more
-
Duarte, California
- +7 more
Jul 20, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +94 more
Jun 9, 2022
MDS Trial in Houston (Sertraline, Bone Marrow Aspirate/Biopsy)
Terminated
- Myelodysplastic Syndromes
- Sertraline
- Bone Marrow Aspirate/Biopsy
-
Houston, Texas
- +1 more
May 31, 2022
Thrombocytopenia, Hematologic Malignancy, Bone Marrow Aplasia Trial in Israel, Norway, United States (Thrombosomes, Liquid
Suspended
- Thrombocytopenia
- +5 more
- Thrombosomes
- Liquid Stored Platelets (LSP)
-
Duarte, California
- +5 more
Apr 21, 2022